Related Experiment Video
Updated: Jul 19, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis
R A Larsen1, M Bauer, A E Brouwer
1Department of Medicine (Infectious Diseases), 2020 Zonal Ave., IRD Room 620, MC 9520, University of Southern California, Los Angeles, CA 90033, USA. rlarsen@usc.edu
Accurate antifungal drug susceptibility testing is crucial. This study shows a strong link between in vitro amphotericin B susceptibility of Cryptococcus neoformans and patient treatment outcomes.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Antifungal drug resistance poses a significant clinical challenge.
- Cryptococcus neoformans is an important fungal pathogen.
- Reliable methods for assessing antifungal susceptibility are essential for guiding treatment.
Purpose of the Study:
- To evaluate the in vitro susceptibility of Cryptococcus neoformans to amphotericin B.
- To correlate in vitro antifungal susceptibility with clinical outcomes in patients.
Main Methods:
- Utilized a modified broth macrodilution method for antifungal susceptibility testing.
- Tested Cryptococcus neoformans isolates from patients undergoing amphotericin B treatment.
Main Results:
- Demonstrated a strong correlation between quantitative in vitro amphotericin B susceptibility measures.
- Observed a significant relationship between in vitro results and quantitative patient response.
Conclusions:
- Quantitative in vitro antifungal susceptibility testing provides reliable predictions of treatment response.
- This method can aid in optimizing antifungal therapy for Cryptococcus neoformans infections.
More Related Videos
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
07:19A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 21, 2010
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Amebiasis